Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Importance: Untreated syphilis infection during pregnancy can be passed to the fetus, causing congenital syphilis. Congenital syphilis is associated with premature birth, low birth weight, stillbirth, neonatal death, and significant abnormalities in the infant such as deformed bones, anemia, enlarged liver and spleen, jaundice, brain and nerve problems (eg, permanent vision or hearing loss), and meningitis. In 2023, there were 3882 cases of congenital syphilis in the US, including 279 congenital syphilis-related stillbirths and neonatal/infant deaths, the highest number reported in more than 30 years.
Objective: The US Preventive Services Task Force (USPSTF) commissioned a reaffirmation evidence update focused on the benefits and harms of screening for syphilis infection in pregnancy.
Population: Adolescents and adults who are pregnant.
Evidence Assessment: The USPSTF concludes with high certainty that screening for syphilis infection in pregnancy has a substantial net benefit.
Recommendation: The USPSTF recommends early, universal screening for syphilis infection during pregnancy; if an individual is not screened early in pregnancy, the USPSTF recommends screening at the first available opportunity. (A recommendation).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/jama.2025.5009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Implications of high prevalence of recreational drug use among cases of infectious syphilis: insights from state-wide surveillance data, South Australia, July 2022 - September 2023.
Commun Dis Intell (2018)
February 2025
Communicable Disease Control Branch, SA Health, Adelaide, South Australia, Australia; Adelaide Sexual Health Centre, Central Adelaide Local Health Network, Adelaide, South Australia, Australia; Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.
Background: Both injecting drug use (IDU) and drug use by non-injecting routes only (non-IDU) are recognised internationally as behavioural risk factors for syphilis. In Australia, this association has predominantly been assessed in sexual health services. To generate evidence supporting regular screening and timely symptomatic testing of all at-risk populations, South Australia in 2022 commenced routine collection of drug use information for statutory syphilis surveillance.
View Article and Find Full Text PDFLaboratory-based syphilis lateral flow immunoassay testing for maternity care at Alice Springs Hospital: a pilot study.
Commun Dis Intell (2018)
February 2025
Microbiology Department, Territory Pathology, Royal Darwin Hospital, Darwin, Australia.
Congenital syphilis is a preventable yet severe condition resulting from untreated maternal syphilis. Since 2016, Australia has recorded over 95 congenital syphilis cases, with 31/95 (33%) associated with perinatal death. Syphilis serology is complex and therefore performed in designated central laboratories.
View Article and Find Full Text PDFAssociation between maternal sexually transmitted diseases and birth defects in the United States: A nationwide population-based study.
Ann Epidemiol
September 2025
School of Public Health, Peking University, Beijing, China. Electronic address:
Purpose: We estimated the association between maternal sexually transmitted diseases (STDs) and the risk of specific birth defects among live singleton births in the United States (US).
Methods: We conducted a population-based study using data from birth certificates for 14,602,822 live singleton births occurring from 2016 to 2019 in the US. We used logistic regression to estimate the associations between three maternal STDs (chlamydia, gonorrhea, and syphilis) and the risk of four specific birth defects (gastroschisis, cleft lip with or without cleft palate, spina bifida, and hypospadias), adjusting for socio-demographic and pregnancy-related factors.
DoxyPEP: Opportunities for Expansion.
J Prim Care Community Health
September 2025
Department of Medicine, University of Chicago, Chicago, Illinois, USA.
Clinical trials show that doxycycline post-exposure prophylaxis (DoxyPEP) significantly reduces the risk of bacterial sexually transmitted infections (STIs), especially syphilis and chlamydia, in cisgender men who have sex with men and transgender women. Real-world data suggest DoxyPEP may be beneficial for other populations disproportionately affected by STIs. Given the ongoing STI epidemic we recommend discussing DoxyPEP with all eligible patients.
View Article and Find Full Text PDFTrends Analysis of Sexually Transmitted Infections Before and After Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States 2001-2022.
Open Forum Infect Dis
September 2025
Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Background: The correlation between human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) usage and sexually transmitted infections (STIs) remains equivocal. Limited studies have investigated national STI trends after introducing PrEP. We aimed to examine STI incidence before and after PrEP introduction and explore correlations with PrEP use in the United States.
View Article and Find Full Text PDF